MMD2
geneOn this page
Also known as PAQR10
Summary
MMD2 (monocyte to macrophage differentiation associated 2, HGNC:30133) is a protein-coding gene on chromosome 7p22.1, encoding Monocyte to macrophage differentiation factor 2 (Q8IY49).
This gene encodes a member of the PAQR (progestin and adipoQ receptor) family. Members of this family are evolutionarily conserved with significant sequence identity to bacterial hemolysin-like proteins and are defined by a set of seven transmembrane domains. The protein encoded by this gene localizes to the Golgi apparatus to modulate Ras signaling. Alternative splicing results in multiple transcript variants and protein isoforms.
Source: NCBI Gene 221938 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_198403
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30133 |
| Approved symbol | MMD2 |
| Name | monocyte to macrophage differentiation associated 2 |
| Location | 7p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PAQR10 |
| Ensembl gene | ENSG00000136297 |
| Ensembl biotype | protein_coding |
| OMIM | 614581 |
| Entrez | 221938 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000401401, ENST00000404774, ENST00000406755, ENST00000963657
RefSeq mRNA: 3 — MANE Select: NM_198403
NM_001100600, NM_001270375, NM_198403
CCDS: CCDS47529, CCDS47530, CCDS59047
Canonical transcript exons
ENST00000401401 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000923856 | 4920171 | 4920331 |
| ENSE00000976404 | 4911145 | 4911246 |
| ENSE00001307374 | 4925451 | 4925532 |
| ENSE00001562968 | 4909881 | 4909950 |
| ENSE00001706338 | 4916005 | 4916079 |
| ENSE00001831476 | 4905998 | 4907599 |
| ENSE00003907090 | 4958971 | 4959187 |
Expression profiles
Bgee: expression breadth broad, 85 present calls, max score 87.44.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6523 / max 40.2491, expressed in 107 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 82556 | 0.6523 | 107 |
Top tissues by expression
229 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 87.44 | gold quality |
| spinal cord | UBERON:0002240 | 86.71 | gold quality |
| nucleus accumbens | UBERON:0001882 | 85.17 | gold quality |
| caudate nucleus | UBERON:0001873 | 85.11 | gold quality |
| putamen | UBERON:0001874 | 84.92 | gold quality |
| amygdala | UBERON:0001876 | 83.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.32 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 80.99 | gold quality |
| endothelial cell | CL:0000115 | 80.96 | gold quality |
| substantia nigra | UBERON:0002038 | 79.87 | gold quality |
| hypothalamus | UBERON:0001898 | 79.48 | gold quality |
| midbrain | UBERON:0001891 | 78.97 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.87 | gold quality |
| pancreatic ductal cell | CL:0002079 | 78.77 | silver quality |
| right frontal lobe | UBERON:0002810 | 78.77 | gold quality |
| temporal lobe | UBERON:0001871 | 78.34 | gold quality |
| tibialis anterior | UBERON:0001385 | 77.80 | silver quality |
| forebrain | UBERON:0001890 | 77.23 | gold quality |
| neocortex | UBERON:0001950 | 77.02 | gold quality |
| buccal mucosa cell | CL:0002336 | 76.85 | gold quality |
| frontal cortex | UBERON:0001870 | 76.59 | gold quality |
| Ammon’s horn | UBERON:0001954 | 76.49 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 76.07 | gold quality |
| cerebral cortex | UBERON:0000956 | 76.01 | gold quality |
| brain | UBERON:0000955 | 75.83 | gold quality |
| primary visual cortex | UBERON:0002436 | 75.79 | gold quality |
| upper arm skin | UBERON:0004263 | 75.37 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.88 | gold quality |
| ventricular zone | UBERON:0003053 | 74.69 | gold quality |
| occipital lobe | UBERON:0002021 | 73.96 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
62 targeting MMD2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-9851-3P | 99.63 | 69.68 | 1110 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-409-3P | 99.50 | 66.33 | 1192 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-516A-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-516B-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-7162-5P | 99.46 | 68.08 | 1368 |
| HSA-MIR-365A-3P | 99.43 | 70.02 | 836 |
| HSA-MIR-365B-3P | 99.43 | 70.02 | 836 |
| HSA-MIR-520A-5P | 99.35 | 66.72 | 1632 |
| HSA-MIR-525-5P | 99.35 | 66.85 | 1615 |
| HSA-MIR-593-5P | 99.34 | 69.50 | 965 |
| HSA-MIR-3064-5P | 99.26 | 66.13 | 1497 |
Literature-anchored findings (GeneRIF, showing 2)
- Collectively, this study uncovers a new paradigm of spatial regulation of Ras signaling in the Golgi apparatus by PAQR10 and PAQR11. (PMID:21968647)
- results of the present study indicate that Golgi localization is indispensable for PAQR10 to implement its regulatory functions in the Ras signalling cascade (PMID:22339580)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mmd2a | ENSDARG00000087446 |
| danio_rerio | mmd2b | ENSDARG00000089090 |
| ENSDARG00000108505 | ||
| mus_musculus | Mmd2 | ENSMUSG00000039533 |
| rattus_norvegicus | Mmd2 | ENSRNOG00000001113 |
| drosophila_melanogaster | AdipoR | FBGN0038984 |
| caenorhabditis_elegans | WBGENE00016610 | |
| caenorhabditis_elegans | WBGENE00019643 |
Paralogs (10): ADIPOR2 (ENSG00000006831), MMD (ENSG00000108960), PAQR5 (ENSG00000137819), ADIPOR1 (ENSG00000159346), PAQR6 (ENSG00000160781), PAQR4 (ENSG00000162073), PAQR3 (ENSG00000163291), PAQR8 (ENSG00000170915), PAQR7 (ENSG00000182749), PAQR9 (ENSG00000188582)
Protein
Protein identifiers
Monocyte to macrophage differentiation factor 2 — Q8IY49 (reviewed: Q8IY49)
Alternative names: Progestin and adipoQ receptor family member 10, Progestin and adipoQ receptor family member X
All UniProt accessions (1): Q8IY49
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Golgi apparatus membrane.
Tissue specificity. Shows restricted expression with highest levels in brain and testis.
Similarity. Belongs to the ADIPOR family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IY49-1 | 1 | yes |
| Q8IY49-2 | 2 | |
| Q8IY49-3 | 3 |
RefSeq proteins (3): NP_001094070, NP_001257304, NP_940685* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004254 | AdipoR/HlyIII-related | Family |
Pfam: PF03006
UniProt features (21 total): topological domain 8, transmembrane region 7, sequence conflict 3, splice variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IY49-F1 | 87.62 | 0.62 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 93 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, BENPORATH_ES_WITH_H3K27ME3, GOBP_REGULATION_OF_PHOSPHORYLATION, GOBP_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY, GOBP_NEUROGENESIS, chr7p22, GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY, ACCAATC_MIR509, JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, GOBP_REGULATION_OF_NEURON_DIFFERENTIATION, GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION, GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS
GO Biological Process (4): regulation of protein localization (GO:0032880), positive regulation of neuron differentiation (GO:0045666), positive regulation of protein kinase activity (GO:0045860), positive regulation of Ras protein signal transduction (GO:0046579)
GO Molecular Function (3): protein kinase activity (GO:0004672), protein binding (GO:0005515), pore-forming activity (GO:0140911)
GO Cellular Component (4): Golgi membrane (GO:0000139), perinuclear region of cytoplasm (GO:0048471), Golgi apparatus (GO:0005794), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 2 |
| cellular anatomical structure | 2 |
| intracellular protein localization | 1 |
| regulation of localization | 1 |
| neuron differentiation | 1 |
| positive regulation of cell differentiation | 1 |
| regulation of neuron differentiation | 1 |
| positive regulation of protein phosphorylation | 1 |
| protein kinase activity | 1 |
| positive regulation of kinase activity | 1 |
| regulation of protein kinase activity | 1 |
| Ras protein signal transduction | 1 |
| regulation of Ras protein signal transduction | 1 |
| positive regulation of small GTPase mediated signal transduction | 1 |
| kinase activity | 1 |
| phosphotransferase activity, alcohol group as acceptor | 1 |
| catalytic activity, acting on a protein | 1 |
| binding | 1 |
| molecular_function | 1 |
| Golgi apparatus | 1 |
| bounding membrane of organelle | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1496 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MMD2 | DYSF | O75923 | 854 |
| MMD2 | ANO5 | Q75V66 | 853 |
| MMD2 | PAQR3 | Q6TCH7 | 634 |
| MMD2 | ADD2 | P35612 | 493 |
| MMD2 | F10 | P00742 | 492 |
| MMD2 | ZNF358 | Q9NW07 | 447 |
| MMD2 | PAQR8 | Q8TEZ7 | 439 |
| MMD2 | PAQR7 | Q86WK9 | 397 |
| MMD2 | PAQR5 | Q9NXK6 | 392 |
| MMD2 | ZCCHC24 | Q8N2G6 | 389 |
| MMD2 | PAQR4 | Q8N4S7 | 385 |
| MMD2 | ADIPOQ | Q15848 | 373 |
| MMD2 | LY96 | Q9Y6Y9 | 355 |
| MMD2 | PAQR9 | Q6ZVX9 | 354 |
| MMD2 | ZPLD1 | Q8TCW7 | 346 |
IntAct
1 interactions, top by confidence:
BioGRID (8): MMD2 (Two-hybrid), MMD2 (Two-hybrid), MMD2 (Two-hybrid), TMEM14B (Two-hybrid), CREB3L1 (Two-hybrid), ASGR2 (Two-hybrid), SSMEM1 (Two-hybrid), SGPL1 (Two-hybrid)
ESM2 similar proteins: A0A1B0GVZ9, A4IFN5, A5PK40, A6NH52, A6NI61, B2LYG4, B2RZC9, B6ID01, D2HKB0, D3ZG27, P86229, Q0VDI3, Q15012, Q15546, Q17QJ2, Q1RLT2, Q2TA01, Q4R4I5, Q4R6E8, Q5H8A4, Q5R7Q1, Q5RAH0, Q5RL79, Q5U3C3, Q5VTY9, Q5ZML7, Q64232, Q6PHN7, Q6QRN8, Q719N3, Q71SV0, Q8BWB6, Q8IY49, Q8N6M3, Q8NFT2, Q8R189, Q8VD53, Q8VDI9, Q8VDR5, Q9CQC4
Diamond homologs: P67153, P67154, P67155, P67156, Q15546, Q719N3, Q8IY49, Q8R189, Q9CQY7, P54176
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1874 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:4907595:TTGGG:T | acceptor_gain | 1.0000 |
| 7:4907596:TGGG:T | acceptor_gain | 1.0000 |
| 7:4907598:GG:G | acceptor_gain | 1.0000 |
| 7:4907600:C:CC | acceptor_gain | 1.0000 |
| 7:4907605:G:T | acceptor_gain | 1.0000 |
| 7:4911143:A:AC | donor_gain | 1.0000 |
| 7:4911144:C:CC | donor_gain | 1.0000 |
| 7:4911144:CCG:C | donor_gain | 1.0000 |
| 7:4915997:GTACT:G | donor_loss | 1.0000 |
| 7:4915999:ACT:A | donor_loss | 1.0000 |
| 7:4916000:CTCA:C | donor_loss | 1.0000 |
| 7:4916001:TCA:T | donor_loss | 1.0000 |
| 7:4916002:CA:C | donor_loss | 1.0000 |
| 7:4916003:A:AC | donor_gain | 1.0000 |
| 7:4916003:AC:A | donor_gain | 1.0000 |
| 7:4916004:C:CC | donor_gain | 1.0000 |
| 7:4916004:C:CT | donor_loss | 1.0000 |
| 7:4916004:CC:C | donor_gain | 1.0000 |
| 7:4925450:CAG:C | donor_gain | 1.0000 |
| 7:4958967:TCACC:T | donor_loss | 1.0000 |
| 7:4958968:CA:C | donor_loss | 1.0000 |
| 7:4958969:ACCTC:A | donor_loss | 1.0000 |
| 7:4958970:CCTCG:C | donor_gain | 1.0000 |
| 7:4907597:GGG:G | acceptor_gain | 0.9900 |
| 7:4907597:GGGC:G | acceptor_loss | 0.9900 |
| 7:4907600:C:CA | acceptor_loss | 0.9900 |
| 7:4907607:C:CT | acceptor_gain | 0.9900 |
| 7:4907608:A:T | acceptor_gain | 0.9900 |
| 7:4909874:CACTT:C | donor_loss | 0.9900 |
| 7:4909875:ACTTA:A | donor_loss | 0.9900 |
AlphaMissense
1633 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:4907472:C:T | G246D | 0.999 |
| 7:4907491:G:C | H240D | 0.999 |
| 7:4907494:A:G | W239R | 0.999 |
| 7:4907494:A:T | W239R | 0.999 |
| 7:4916050:T:A | D107V | 0.999 |
| 7:4916050:T:G | D107A | 0.999 |
| 7:4920202:G:C | H87D | 0.999 |
| 7:4920314:G:C | S49R | 0.999 |
| 7:4920314:G:T | S49R | 0.999 |
| 7:4920316:T:G | S49R | 0.999 |
| 7:4925470:G:T | A37D | 0.999 |
| 7:4907489:A:C | H240Q | 0.998 |
| 7:4907489:A:T | H240Q | 0.998 |
| 7:4907490:T:C | H240R | 0.998 |
| 7:4907491:G:T | H240N | 0.998 |
| 7:4907501:G:C | H236Q | 0.998 |
| 7:4907501:G:T | H236Q | 0.998 |
| 7:4907503:G:C | H236D | 0.998 |
| 7:4907544:C:T | G222D | 0.998 |
| 7:4907545:C:G | G222R | 0.998 |
| 7:4911194:A:G | W140R | 0.998 |
| 7:4911194:A:T | W140R | 0.998 |
| 7:4911244:A:G | L123P | 0.998 |
| 7:4916006:A:G | W122R | 0.998 |
| 7:4916006:A:T | W122R | 0.998 |
| 7:4916047:C:G | R108P | 0.998 |
| 7:4920203:A:C | F86L | 0.998 |
| 7:4920203:A:T | F86L | 0.998 |
| 7:4920205:A:G | F86L | 0.998 |
| 7:4920221:G:C | F80L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000022450 (7:4924589 C>T), RS1000092962 (7:4935297 A>C,G), RS1000097617 (7:4955490 T>G), RS1000212583 (7:4901231 A>G), RS1000226400 (7:4961040 G>A), RS1000251171 (7:4896058 G>A,C), RS1000274279 (7:4926839 G>A), RS1000278505 (7:4926738 CTTT>C,CTT,CTTTT), RS1000370164 (7:4935728 G>C), RS1000382893 (7:4932337 G>A), RS1000412399 (7:4932606 C>T), RS1000424361 (7:4900805 C>G,T), RS1000480419 (7:4930824 C>T), RS1000492177 (7:4898770 G>A,C,T), RS1000533100 (7:4955272 T>C)
Disease associations
OMIM: gene MIM:614581 | disease phenotypes:
GenCC curated gene-disease
Mondo (1): megacolon (MONDO:0001273)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D008531 | Megacolon | C06.405.469.158.701 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT04340856 | Not specified | COMPLETED | Retrospective, Uncontrolled Cohort Study on the Therapy of Chronic Megalon |
| NCT07470892 | Not specified | NOT_YET_RECRUITING | Preoperative Fish Oil PN and Prognosis After Constipation Surgery |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): megacolon